Search research articles
Contact Us
Filters
Showing results (51-60 of 441) with videos related to
Page
of 45
Sort By:
Nephrologie & Therapeutique
|
October 2, 2015
[Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure]
Anaïs Vallet-Pichard, Stanislas Pol
Alimentary Pharmacology & Therapeutics
|
April 28, 2021
Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma
Anaïs Vallet-Pichard, Stanislas Pol
Clinics and Research in Hepatology and Gastroenterology
|
August 13, 2013
Hepatitis C virus infection in hemodialysis patients
Anais Vallet-Pichard, Stanislas Pol
Therapeutic Advances in Gastroenterology
|
March 14, 2017
Grazoprevir/elbasvir combination therapy for HCV infection
Anaïs Vallet-Pichard, Stanislas Pol
Expert Opinion on Biological Therapy
|
August 22, 2006
Improving anti-hepatitis C virus therapy
Stanislas Pol, Vincent O Mallet
Journal of Hepatology
|
December 14, 2005
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection
Anaïs Vallet-Pichard, Stanislas Pol
Discovery Medicine
|
January 20, 2007
Improving anti-HCV therapy
Stanislas Pol, Vincent O Mallet
Therapeutic Advances in Gastroenterology
|
July 25, 2014
Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal
Anais Vallet-Pichard, Stanislas Pol
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 4, 2012
IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?
Donald M Jensen, Stanislas Pol
Nature Reviews. Nephrology
|
November 21, 2018
Hepatitis C virus and the kidney
Stanislas Pol, Lucia Parlati, Michel Jadoul
Page
of 45
Search research articles
Search
Showing results (51-60 of 441) with videos related to
Sort By:
Page
of 45
Nephrologie & Therapeutique
|
October 2, 2015
[Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure]
Anaïs Vallet-Pichard, Stanislas Pol
Alimentary Pharmacology & Therapeutics
|
April 28, 2021
Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma
Anaïs Vallet-Pichard, Stanislas Pol
Clinics and Research in Hepatology and Gastroenterology
|
August 13, 2013
Hepatitis C virus infection in hemodialysis patients
Anais Vallet-Pichard, Stanislas Pol
Therapeutic Advances in Gastroenterology
|
March 14, 2017
Grazoprevir/elbasvir combination therapy for HCV infection
Anaïs Vallet-Pichard, Stanislas Pol
Expert Opinion on Biological Therapy
|
August 22, 2006
Improving anti-hepatitis C virus therapy
Stanislas Pol, Vincent O Mallet
Journal of Hepatology
|
December 14, 2005
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection
Anaïs Vallet-Pichard, Stanislas Pol
Discovery Medicine
|
January 20, 2007
Improving anti-HCV therapy
Stanislas Pol, Vincent O Mallet
Therapeutic Advances in Gastroenterology
|
July 25, 2014
Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal
Anais Vallet-Pichard, Stanislas Pol
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 4, 2012
IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?
Donald M Jensen, Stanislas Pol
Nature Reviews. Nephrology
|
November 21, 2018
Hepatitis C virus and the kidney
Stanislas Pol, Lucia Parlati, Michel Jadoul
Page
of 45